Enveric Biosciences (STU:SLZ0) ROE % Adjusted to Book Value: -5.90% (As of Mar. 2026)


STU:SLZ0 Enveric Biosciences Inc STU:SLZ0
30 GF Score
Price €55.89
! 1 Warning Sign
View Full Analysis

What is Enveric Biosciences ROE % Adjusted to Book Value?

Enveric Biosciences STU:SLZ0 30 ROE % Adjusted to Book Value is -5.90% as of Mar. 2026. GuruFocus rates STU:SLZ0 with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Enveric Biosciences's ROE % for the quarter that ended in Mar. 2026 was -142.26%. Enveric Biosciences's PB Ratio for the quarter that ended in Mar. 2026 was 24.10. Enveric Biosciences's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -5.90%.

Enveric Biosciences ROE % Adjusted to Book Value Related Terms

Enveric Biosciences ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Enveric Biosciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enveric Biosciences ROE % Adjusted to Book Value Chart

Enveric Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -252.93 -335.48 -98.04 -251.90 -17.70

Enveric Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -98.82 -42.56 -26.86 -13.84 -5.90

STU:SLZ0 vs APVO, CNSP, ADIL: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Enveric Biosciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enveric Biosciences ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enveric Biosciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Enveric Biosciences's ROE % Adjusted to Book Value falls into.


STU:SLZ0
30GF Score
Enveric Biosciences Inc STU:SLZ0
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enveric Biosciences ROE % Adjusted to Book Value Calculation

Enveric Biosciences's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-294.40% / 16.63
=-17.70%

Enveric Biosciences's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-142.26% / 24.10
=-5.90%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -5.90% mean?
Enveric Biosciences (STU:SLZ0) has a ROE % Adjusted to Book Value of -5.90% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Enveric Biosciences and its competitors.
Is Enveric Biosciences' ROE % Adjusted to Book Value too high?
Enveric Biosciences' current ROE % Adjusted to Book Value is -5.90%. Overall, Enveric Biosciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Enveric Biosciences' ROE % Adjusted to Book Value compare to APVO and CNSP?
Enveric Biosciences' ROE % Adjusted to Book Value of -5.90% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Enveric Biosciences and its competitors. Enveric Biosciences's current ROE % Adjusted to Book Value is -5.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enveric Biosciences stock overvalued right now?
Enveric Biosciences (STU:SLZ0) has a current ROE % Adjusted to Book Value of -5.90%. The current ROE % Adjusted to Book Value is -5.90%. Enveric Biosciences' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Enveric Biosciences (STU:SLZ0), the current ROE % Adjusted to Book Value is -5.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enveric Biosciences Business Description

Other Exchanges ENVB:USA
Address 245 First Street, 18th Floor, Riverview II, Cambridge, MA, USA, 02142
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
30GF Score

Get the complete analysis for STU:SLZ0

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.89
Price